Mumbai: Global pharma major Lupin Limited has announced that it has launched Rivaroxaban Tablets USP, 2.5 mg, following the ...

This prospective cohort study first presented evidence for clinical use of an angiotensin receptor blocker in pediatric pulmonary vein stenosis. We evaluated the novel use of valsartan to attenuate ...